Chemycal has been acquired by 3E

Learn More

An Open-Innovation Test Bed for Medical Devices


Your substances

None


Thirteen European partners aim to accelerate patient access to innovative solutions: The new EU research project TBMED aims to support European med-tech companies in global competition by reducing the time-to-market of high-risk medical devices (MDs). An Open Innovation test bed for the development of devices of risk classification IIb and higher will provide expert support from an early development stage to the optimised transformation of prototypes into valuable and innovative products.

CONTINUE READING ON cordis.europa.eu

                   

Related News

Loading...